Shows
pplpodGiant in the Shadows: The Billions, Battles, and Rebrand of CencoraIn this episode, we pull back the curtain on Cencora, the company formerly known as AmerisourceBergen. Despite handling nearly 20% of all pharmaceuticals sold in the United States, this industry titan often operates behind the scenes. We trace its origins from the 2001 merger of AmeriSource and Bergen Brunswig to its evolution into a global powerhouse with over $300 billion in annual revenue.We dig deep into the controversies that have plagued the distributor, including its central role in the American Opioid Epidemic, which led to a historic $26 billion settlement with states and local governments. You’ll hear about the "PF...
2025-12-1837 min
Technovation with Peter High (CIO, CTO, CDO, CXO Interviews)The CIO as Change Agent and Ecosystem BuilderWhat if your AI strategy is your business strategy?
In this episode, three top tech leaders share how they’re embedding AI not as a standalone initiative, but as a lever for enterprise transformation.
Mojgan Lefebvre (Travelers), Pawan Verma (Cencora), and Glenn Remoreras (Breakthru Beverage) reveal how they’ve partnered with boards, business units, and frontline teams to scale AI from proof of concept to performance.
Highlights include:
How Travelers reduced onboarding from 2 hours to 2 minutes
Cencora’s framework for board-level AI education
Breakthru’s use of summits to build AI literacy across l...
2025-12-1833 min
HITshow Daily Audio NewscastHITshow Daily: December 15, 2025 (Monday)Today on HITshow:
Stability is getting expensive across healthcare. The VA plans to eliminate up to 35,000 healthcare positions, 57 health systems push back on proposed cybersecurity rules, and Cencora takes majority control of OneOncology in a $7.4B deal. Plus: Connecticut approves a hospital acquisition with strict access guardrails, and Philips moves to acquire SpectraWAVE for AI-enabled coronary imaging.
HOST: RHONDA BROOKS
📍 Healthcare Policy & Advocacy --- Anika Shah
The Veterans Affairs system is planning to cut up to 35,000 healthcare positions, largely roles currently unfilled. The concern for hospital leaders isn't just federal belt-tightening but second-order effects: if VA capacity tightens or hiring slo...
2025-12-1508 min
Philadelphia Job Market ReportPhiladelphia's Resilient Job Market: Steady Growth, Cautious Outlook, and Emerging OpportunitiesPhiladelphia's job market remains resilient amid national uncertainties, including the 2025 federal government shutdown that disrupted October data collection according to the Bureau of Labor Statistics. The employment landscape features steady growth in professional services, healthcare, and education, with major employers like Comcast, Cencora, universities, and hospitals driving opportunities. Key statistics show national unemployment hovering around 4.4 to 5.1 percent per Trading Economics forecasts, though Philadelphia-specific figures for late 2025 are unavailable due to BLS data gaps from the shutdown; local manufacturing sentiment dipped to negative 1.7 in the Philadelphia Fed index.Trends indicate softening payrolls with national estimates at 35,000 to 50,000 jobs added...
2025-12-1502 min
The Bird BathDigitail $23M Series B, Cencora and MWI, Chewy Claus, and Access to Care AgainSecond week of November, what’d you miss in vet med?Digitail closes $23M Series BCencora moves MWI to OtherMedivet embraces PartnersChewy Claus is readyA New Study of Perception of Access to CareHelpful links:The Bird Bath substackPearl: Hybrid Intelligence - Veterinary AI platformСhewy СlausFrontiers - U.S. residents’ self-reported access to veterinary care and implications for care-seeking decisions
2025-11-1114 min
Daily Market DownloadCencora Fourth Quarter Fiscal 2025 Earnings CallThese sources consist of a press release and a slide presentation detailing Cencora, Inc.'s financial and strategic performance for the fourth quarter and full fiscal year 2025, which concluded on September 30, 2025. The documents highlight strong financial results, including a 5.9% increase in quarterly revenue and a 15.0% increase in adjusted diluted earnings per share for the quarter, largely attributed to growth in the U.S. Healthcare Solutions segment and the acquisition of RCA. Furthermore, Cencora announced increased long-term guidance expectations, outlined a $1 billion investment plan to enhance its U.S. distribution network, and revealed plans to reorganize its segment...
2025-11-0617 min
Radio SalusLe terapie avanzate
In questa puntata di Informaradio, dedicata alle terapie avanzate, Roberto Bonin intervista:
Chiara Lucchetti, Patient Access Director di Cencora Pharmalex e membro del Comitato
direttivo di ATMP Forum
Marianna Morani, Market Access Senior Manager at Cencora PharmaLex & Project Manager
ATMP Forum
Avvertenza: Si ricorda che questo è un contenuto di intrattenimento, prima di assumere decisioni di qualsiasi tipo vi invitiamo a consultare il vostro medico curante o il professionista di vostra fiducia.
Pareri, risposte, dichiarazioni o contenuti espressi dai produttori, editori, conduttori, dai professionisti o dagli ospiti di questa rubrica sono strettamente personali e...
2025-10-2325 min
OnCallQ3 GPO Legislative TownhallIn this episode, Joel White, Partner and Head of Health Practice at Monument Advocacy, will discuss the Medicare physician fee schedule proposed rule and impact on practices and manufacturers, end of the year health priorities for congress, and Trump Administration goals, plans and efforts on drug pricing/MFN.If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions...
2025-10-0935 minOnCallInflation Reduction Act: Current StateIn this episode, Whitley Quan, Manager of Cencora's U.S. Public Policy will be speaking on the current state of IRA implementation and what Cencora is doing to help its customer prepare for IRA deadlines.For IRA specific questions, please reach out to IRAsupport@cencora.com. If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and...
2025-08-1409 minOnCallQ2 GPO Legislative TownhallIn this episode, Joel White, President and CEO of Horizon Government Affairs will be speaking on budget bill and payment updates for physicians, CMMI reforms for value-based care, CMS focus on technology assisted care, and drug price reforms.If you have questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The...
2025-07-3149 minOnCallInflation Reduction Act: OverviewIn this episode, the first of our new Inflation Reduction Act series, Cencora's VP of Market Economics, Tyler Novotny, and Megan Law, Sr. Director of Specialty GPO Portfolio Accounts, will give an overview of IRA and dive into IRA impact on patients, manufacturers, and providers.If you have questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by...
2025-07-2215 min
Esker On AirSeason 6 Episode 7: Cencora’s Automation Journey to the Modern Office of the CFOListen to Season 6 Ep. 7 of Esker On Air to hear how Cencora — a global pharmaceutical solutions provider and Fortune 10 company — is empowering their Office of the CFO to deliver growth and make smart strategic decisions using AI-driven technology. Three Cencora executives share the successes they’re seeing after automating source-to-pay and order-to-cash processes. Learn their implementation strategies, how they leverage various AI technologies and their advice to businesses looking to automate. Resources:Esker: info@esker.comContact Us [Click Here]3 Takeaways About the Office of the CFO from Esker All Access 2025 [Blog]
2025-07-1020 min
pharmaphorum PodcastThe changing landscape of drug clinical assessment: Tommy Bramley on the JCAThe JCA process was passed into law by the European Union in 2022. The Joint Clinical Assessment is a process that will systematically assess all available clinical evidence for new drugs. Rolled out in stages, starting with oncology drugs and advanced therapy medicinal products this year, it will be fully implemented by 2030.
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Tommy Bramley, SVP of market access and healthcare consulting at Cencora, about the JCA, as yet unanswered questions (at the time of the conversation) and the key challenges facing manufacturers.
Bramley also discusses...
2025-06-2418 min
WeInfuse's PodcastEpisode 73: How to Enthusiastically Embrace Infusion Strategy, Safety, and Analytics with Brenda Matthews, PharmDIn this episode, we talk with Brenda Matthews, Director of Infusion Strategy at Cencora. Brenda shares her journey into the infusion industry, insights from her deep background in patient safety, and her work helping infusion centers optimize operations with analytics, inventory management, and enterprise strategy. You’ll also hear about the exciting partnership between Cencora and WeInfuse—and Brenda’s top advice for infusion providers looking to strengthen their safety practices.
2025-05-2117 minOnCall505(b)(2) Operationalizing in Practice - Provider PerspectiveIn this episode, the final of our 505(b)(2) series, sponsored by Avyxa, we are joined by Dr. Fred Divers, Chief Medical Officer for American Oncology Network, and Dr. Ralph Boccia, hematologist oncologist, member of American Oncology Network, and the International Oncology Network's Chief Medical Officer, who will discuss operationalizing in practice from a provider perspective.If you have questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical...
2025-05-1320 min
pharmaphorum PodcastThe value of a partner, globally and locallyWith the FDA and EMA releasing their annual reports detailing novel drug approvals in 2024, a new pharmaphorum podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face in the year ahead.
Host Nicole Raleigh is joined by Cencora’s Sandra Anderson, SVP of International Commercialisation, and Chris Williams, SVP & International Managing Director at Alloga Europe and ICS, which are part of Cencora – and the conversation dives into takeaways such as the increase in smaller biotech companies taking their product to market on their own, what is n...
2025-05-0922 minOnCall505(b)(2) Operationalizing in Practice - Pharmacist PerspectiveIn this episode, the fourth of our 505(b)(2) series, sponsored by Avyxa, we are joined by James Gilmore, Chief Pharmacy and Clinical Services Officer at American Oncology Network, and Joe Shupp, VP of Sales for Cencora's ION Oncology Network, who will discuss operationalizing in practice from a pharmacist perspective.If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com.Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are...
2025-05-0110 minOnCall505(b)(2) Billing and ReimbursementIn this episode, the third of our 505(b)(2) series, sponsored by Avyxa, we are joined by Jonas Congelli, Chief Strategy Officer at Hematology-Oncology Associates of Central New York, Kyle Kitchen, Senior Director at Utah Cancer Specialists, and Trey McNiel, Senior Director of Sales for Cencora's ION Oncology Network East Region, discuss billing and reimbursement of 505(b)(2)s.If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com.Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice...
2025-04-1739 minOnCall505(b)(2) Landscape and PipelineIn this episode, the second of our 505(b)(2) series, sponsored by Avyxa, we are joined by Jonas Congelli, Chief Strategy Officer at Hematology-Oncology Associates of Central New York, Kyle Kitchen, Senior Director at Utah Cancer Specialists, and Matthew Letow, Senior Director of Sales New Business Development for Cencora's SAN GPO National Accounts, who will discuss the landscape and pipeline of 505(b)(2)s.If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com.Disclaimer: The OnCall podcast is for educational purposes only and not a substitute...
2025-04-0332 min
CDO Magazine Podcast SeriesPODCAST | A 5-Year Plan is Critical, But So is Experimentation — Cencora SVP Enterprise AnalyticsIn this episode, Kyle Pudenz, SVP of Enterprise Analytics at Cencora, sits down with David Zhao, Managing Director at Coda Strategy, to explore:✅ Designing data architecture to tackle integration challenges✅ Balancing data security with business value✅ Unlocking efficiency & decision-making with GenAI✅ The power of knowledge graphs & graph analytics✅ How a 5-year data roadmap fuels long-term innovation💡 Whether you're a data leader, supply chain expert, or AI enthusiast, this conversation is packed with actionable insights.🎧Tune in now!
2025-03-2615 minOnCall505(b)(2) BasicsIn this episode, the first of our 505(b)(2) series, sponsored by Avyxa, we are joined by Zach Horstman, Director of Specialty GPO Corporate Accounts for Cencora, and Yoni Resnick, Director of Pharmacy Clinical Services at New England Cancer Specialists, who will discuss the basics of 505(b)(2)s.If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com.Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only...
2025-03-1830 min
CDO Magazine Podcast SeriesPODCAST | Making Everything Real-time Can Lead to Too Much Noise — Cencora SVP Enterprise AnalyticsKyle Pudenz, SVP, Enterprise Analytics at Cencora, speaks with David Zhao, Managing Director of Coda Strategy, about the role of data speed in business decision-making, addressing supply chain challenges, and balancing real-time insights with long-term strategic planning.
2025-03-1713 min
CDO Magazine Podcast SeriesPODCAST | Don’t Start with Analytics and Look for a Business Problem — Cencora SVP Enterprise AnalyticsKyle Pudenz, SVP, Enterprise Analytics at Cencora, speaks with David Zhao, Managing Director of Coda Strategy, about the organizational data and analytic priorities, challenges the company is addressing, promoting data literacy, taking a probabilistic approach and its impact on business strategy, and the need for collaboration and understanding problems for developing solutions.
2025-02-2614 min
The Top LineLooking ahead at the most anticipated drug launches of 2025If Fierce Pharma Marketing’s annual list of the top 10 biggest potential drug launches of the coming year is any indication, biopharma may soon be in for a blockbuster boom. All together, the 10 meds that made the 2025 list stand to generate a whopping $29 billion in annual sales by the end of the decade. In this week’s episode of The Top Line, we dig into the report’s predictions. Fierce’s Andrea Park and Eric Sagonowsky take a deep dive into the top three drugs on the list—all of which had already snagged their first FDA approvals...
2025-02-0714 minOnCallBuy and Bill: Practice PerspectiveIn this episode, we are joined by Cencora's Specialty Practice Network National Senior Director of Sales for Immunology, Chara Reid, VP Sales for Cencora's Specialty Practice Network, Kortney Cooper, and Elizabeth Johnson, CEO of MedicoCX, who will discuss how buy and bill is implemented in MedicoCX practices.If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com.Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for professional medical advice or clinical judgement. Views expressed are opinions only and not endorsed...
2025-02-0436 min
🇬🇧 Place to beCencora: the “one-stop shop” of independent pharmaciesIn this episode of Place to be, we explore how Cencora is revolutionizing the healthcare sector with its innovative marketplace platform. Jay Dombi, Senior Vice President for Strategic Solutions, shares insights into how the platform empowers independent pharmacies by simplifying front-of-store procurement, fostering community connections, and driving operational efficiency. With a curated catalog of nearly 55,000 SKUs and partnerships with 250+ vetted suppliers, this one-stop-shop solution addresses critical challenges in healthcare and offers lessons for any B2B vertical. Tune in to discover how digitization and innovation can create healthier futures and drive success for small businesses.Place...
2025-02-0440 min
🇫🇷 Place to beCencora : la destination e-commerce unique des pharmacies indépendantes" [Version générée par l'IA à partir de l'épisode enregistré en anglais]Écoutez la version originale : 👉 Spotify👉 Apple Podcasts👉 DeezerDans cet épisode de Place to be, Marc et Jay Dombi, Senior Vice President for Strategic Solutions chez Cencora explorent la manière dont Cencora révolutionne le secteur de la santé avec son modèle de plateforme innovant. Jay détaille comment leur plateforme permet aux pharmacies indépendantes de simplifier l'approvisionnement en magasin, de favoriser les liens au sein de la communauté, et de booster leur efficaci...
2025-02-0436 minThe Top LineWhat to expect from the biotech IPO market in 2025During a panel discussion at this year’s Fierce JPM Week—which took place alongside the annual J.P. Morgan Healthcare Conference in San Francisco—industry experts broke down what it takes to pull off a successful biotech IPO in the current market. This week’s episode of The Top Line dives into the discussion, featuring Fierce Biotech’s Gabrielle Masson as moderator, joined by Septerna CEO and co-founder Jeffrey Finer, M.D., Ph.D.; Rapport Therapeutics Chief Financial Officer Troy Ignelzi; Sofinnova Investments General Partner Maha Katabi, Ph.D.; and Morgan Stanley Executive Director Chirag Surti. In their w...
2025-01-3134 minThe Top LineRecapping the 2025 J.P. Morgan Healthcare ConferenceThis year’s edition of the annual J.P. Morgan Healthcare Conference has come to a close, with attendees enjoying sunny skies and a heavy police presence throughout the San Francisco-set event. In this week’s episode of The Top Line, Fierce Pharma’s Zoey Becker and Angus Liu join Fierce Biotech’s Darren Incorvaia to break down the biggest news stories out of the conference. From Johnson & Johnson’s blockbuster acquisition of Intra-Cellular Therapies to former First Lady Jill Biden’s appearance at Fierce JPM Week just days before she left the White House, this year’s conference se...
2025-01-2420 minOnCallBuy and Bill: The BasicsIn this episode, we are joined by Kortney Cooper, VP of Sales for Cencora's Specialty Practice Network, who will discuss the basics of buy and bill. To find a copy of Kortney's presentation, please visit our OnCall page under Clinical Education on our ION and Specialty Practice Network websites.If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com.Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for professional medical advice or clinical judgement. Views expressed are opinions on...
2025-01-2218 minThe Top LineFierce's forecasts for the next year in biopharmaFollowing the strange year for the biopharma industry that was 2024, insiders and analysts alike are waiting expectantly to see how trends in layoffs, drug shortages, clinical trials and more play out in 2025. Meanwhile, a second Trump term and a spree of related health agency nominations raise serious questions about how health policy could shift over the next 12 months and beyond. In this week’s episode of “The Top Line,” we explore the trends that defined the industry in 2024 and tackle predictions about how 2025 could shake out for biopharmas big and small. Fierce Pharma’s Fraiser Kansteiner and Fierce B...
2025-01-1725 minThe Top LineBreaking down the 55 new drug approvals of 2024A review of the FDA’s drug approvals of 2024 shows that small companies loomed large—both in the sheer number of nods gained and the significance of the new drugs and biologics that these firms are bringing to the market. In this week’s episode of “The Top Line,” we take a deep dive into the FDA’s list of drugs that were approved in 2024. Fierce Pharma’s Kevin Dunleavy and Eric Sagonowsky discuss why biotechs emerged with more approvals than large drugmakers and which new drugs figure to have the most impact for patients. To learn more...
2025-01-1013 minOnCallGPO 101: Legislative TownhallIn this episode, we are joined by Joel White, President of Horizon Government Affairs, who will discuss the Inflation Reduction Act, PBM reform, drug shortages, Medicare physician payment and telehealth issues.If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com.Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for professional medical advice or clinical judgement. Views expressed are opinions only and not endorsed by Cencora or affiliates. Neither OnCall nor Cencora control the accuracy of third party information. Accessing...
2025-01-0838 min
The Road to CareOptimizing Infusion Care: Lessons from WeInfuseSamaCare is joined by WeInfuse founders Reece Norris and Bryan Johnson to discuss the rapidly evolving landscape of infusion care. From managing, to owning, to building software for infusion centers and infusion suites, Reece and Bryan share their experience helping infusion providers get patients from prescription to chair with minimal friction.
You’ll hear:
*Factors driving growth for one of the fastest growing healthcare sectors – Ambulatory Infusion Care (AICs)
*The consumerization of healthcare and how the infusion therapy space is responding
*Technology companies streamlining operations for infusion providers
*BONUS: the best barbecue restaurants in Texas (our host got hungry…)
Together, we can...
2024-11-1823 min
Quality CompoundersCencora: The Unsung Heroes of Healthcare DeliveryCencora, a name you might not know, plays a vital role in the health of millions. Formerly AmerisourceBergen, this global healthcare solutions provider is a key link in the pharmaceutical supply chain, connecting drug manufacturers with patients. This podcast explores Cencora's vast network, its impact on drug access and affordability, and its evolving role in a rapidly changing healthcare landscape. We delve into the challenges of distribution, the complexities of pharmaceutical pricing, and the future of patient care in a world increasingly reliant on complex therapies. Hosted on Acast. See acast.com/privacy for more information.
2024-10-2624 min
Community CornerCencora Inc. Behavior - Episode #696Welcome back to the Community Corner podcast! Today we're exploring the behavioral finance logic of Cencora Inc.! Don't forget to subscribe and leave a like to stay tuned for future episodes! Follow us on Instagram - @communitycorner_podcast Timecodes: 0:15 - Introduction 2:15 - Early Breakthroughs 4:01 - Cencora Inc.’s Role in the Future
2024-10-0906 min
Catalyst Pharmacy PodcastSolve the Pharmacy Puzzle with Antoun Salib | Beyond the Scripts Podcast Episode 61Something you might wish you’d learn in pharmacy school was the business side of the industry. Running a pharmacy means you’re running a business, and businesses need to profit to stay afloat. On this week’s episode of the Catalyst Pharmacy Podcast, join host Mark Bivins as he welcomes Cencora’s Antoun Salib as they discuss the ins and outs of pharmacy coaching, how to leverage your pharmacy technology, and how some non-pharmacy items (puzzles in this case) can drive your pharmacy’s profits.
0:00 - Intro, Antoun’s Story
7:24 - Keep Traditio...
2024-09-0456 min
The Daily ThreatFBI Warns of Crypto Scams, Cencora Data Breach, and Columbus Ransomware Attack!Welcome to another episode of The Daily Threat, your trusted source for the latest in cybersecurity news. In today’s episode, we delve into three significant stories that highlight the evolving landscape of cyber threats. We’ll explore the details of these attacks, how the attackers infiltrated systems, the methods they used, and the risks these incidents pose to businesses. We’ll also provide recommendations and best practices to help you stay protected.Our stories today include:FBI Warns of Scammers Posing as Crypto Exchange Employees:The FBI has issued a warning about scammers targeting indivi...
2024-08-0505 min
Cyber Security HeadlinesCencora patient breach, OneDrive phishing campaign, Argentina’s crime predictionsCencora confirms patient data stolen in February cyberattack Phishing campaign targets OneDrive users Argentina will use AI to predict future crimes Huge thanks to our sponsor, Dropzone AI Picture an analyst who works tirelessly around the clock. Dropzone AI’s Analyst investigates every alert and provides comprehensive, actionable reports. Boost your SOC’s capabilities with a 3-month free trial at dropzone.ai. For the stories behind the headlines, head to CISOseries.com
2024-08-0207 min
CyberHub Podcast🚨 CrowdStrike Legal Challenges Begin, Cencora Breach, Digicert Chaos Ensues, More Regulation🚨 CrowdStrike Legal Challenges Begin, Cencora Breach, Digicert Chaos Ensues, More RegulationJoin us on the CyberHub Podcast as we delve into the latest headlines for cybersecurity practitionersToday’s episode will discuss the legal challenges that Crowdstrike faces following its outage with more news below:Digicert Choas Cencora Data BreachGermany Summons China over Hack For more information, please visit our website: https://www.cyberhubpodcast.com/ 👀 SHOW Supporters:Today’s Episode is supported by our friends at Nudge Security free 14-day trial to all...
2024-08-0116 min
Next Level Supply Chain with GS1 US50 Years of Confidence, Supply Chain Success, and the Next Dimension in BarcodesCelebrating 50 Years of the Barcode, hosts, Reid Jackson and Liz Sertl speak to an impressive lineup of industry experts, direct from Orlando, at GS1 US's yearly conference, Connect. They chat with: Dave DeLaus, CIO at Wegmans, dissects the complexities of integrating new technologies to enhance consumer experience and shares how Wegmans is tackling the challenges of implementing 2D barcodes for better product traceability. Sean Murphy from Cencora demystifies the Drug Supply Chain Security Act and emphasizes the necessity of unique serial numbers and digital backpacks for pharmaceutical products to ensure safety and compliance in the...
2024-06-2632 minNext Level Supply Chain with GS1 US50 Years of Confidence, Supply Chain Success, and the Next Dimension in BarcodesCelebrating 50 Years of the Barcode, hosts, Reid Jackson and Liz Sertl speak to an impressive lineup of industry experts, direct from Orlando, at GS1 US's yearly conference, Connect. They chat with: Dave DeLaus, CIO at Wegmans, dissects the complexities of integrating new technologies to enhance consumer experience and shares how Wegmans is tackling the challenges of implementing 2D barcodes for better product traceability. Sean Murphy from Cencora demystifies the Drug Supply Chain Security Act and emphasizes the necessity of unique serial numbers and digital backpacks for pharmaceutical products to ensure safety and compliance in the...
2024-06-2632 minOnCallBiosimilar Basics: Payer PerspectiveIn this episode, the fourth of our Biosimilars series, Christie Smith discusses the biosimilar payer perspective.If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2024-06-1922 minCyber Security HeadlinesArc browser sabotaged, Cencora pharma breach, Albany County breachArc browser’s Windows launch sabotaged by malvertising Cencora breach exposed patient info from 11 drug companies Albany County investigating cybersecurity breach ahead of holiday weekend Thanks to today's episode sponsor, Vanta Are lengthy security reviews pulling attention away from your security program? With the largest network of Trust Centers, Vanta can help you streamline security reviews to win customer trust, save time, and close deals fast. Proactively demonstrate security by showcasing key resources like your SOC 2 or ISO 27001 and provide real-time evidence for passing controls. An...
2024-05-2706 min
Hacked dAily26-May-2024: Breaches at Cencora, Court Systems, and Replicate AI Raise AlarmWelcome to today's episode of Cyber War Room, your daily roundup of cybersecurity news and updates.
In today's top story, we delve into a massive data breach at medical data giant Cencora. Sensitive patient information from 11 major pharmaceutical companies has been exposed, raising serious privacy concerns across the healthcare sector.
Next, we examine a concerning breach in courtroom recording software due to a supply chain attack. This has put the confidentiality of legal proceedings at risk, with potential access to sensitive recordings now compromised across various jurisdictions.
Our third main story focuses on a critical security flaw discovered in the...
2024-05-2602 minOnCallBiosimilar Basics: LegislationIn this episode, the third of our Biosimilars series, Corey Ford, Vice President of Reimbursement and Policy Insights, and Cristina Muñoz, Senior Director of Head of State Government Advocacy discuss legislation surrounding biosimilars.Our next episode will feature information on the biosimilar payer perspective. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2024-05-2316 minOnCallBiosimilar Basics: Market LandscapeIn this episode, the second of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss the current Biosimilar landscape and what we can expect to see in the market.Our next episode will feature information on biosimilar legislation. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2024-05-0119 minOnCallBiosimilar Basics: OverviewIn this episode, the first of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss Biosimilars 101 and resources to utilize to stay better informed.Our next episode will feature information on the current Biosimilar landscape and what we can expect to see in the market. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2024-04-1717 min
The Talent Pool with Alan KaplanBecoming the CHRO of Tomorrow with Silvana BattagliaSilvana Battaglia, EVP and CHRO at Cencora (formerly AmerisourceBergen), investigates how social issues and hybrid work environments are impacting the balance of power within today’s workforce.
2024-04-0812 min
Hiring MattersHiring (and Onboarding) Matters: Leadership Insights from Target & Cencora with Michelle ByersEver feel like you've hired someone only to watch them vanish into the Bermuda Triangle of new hires? Well, the mystery of successful onboarding is about to be solved! Michelle Byers, a seasoned expert with 17 years of fine-tuning her craft in human capital management at top-tier organizations like Target and Cencora, is going to show you how to guide your new hire toward a smooth landing with air traffic controller expertise. Michelle reveals how to use your team as your co-pilot and unveils the single most crucial activity every leader must undertake within the first 30 days of a new e...
2024-04-0151 min
Community CornerCencora - Episode #175Welcome back to the Community Corner podcast! Today we're exploring the story of Cencora! Don't forget to subscribe and leave a like to stay tuned for future episodes! Follow us on Instagram - @communitycorner_podcast Timecodes: 0:15 - Introduction 2:15 - Early Breakthroughs 4:01 - Cencora's Role in the Future
2024-03-1706 min
Cyber Security HeadlinesCencora pharma breach, Gen-AI explodes BEC, Chinese doorbell warningPharma giant Cencora announces data breach GenAI drives surge in BEC attacks Popular video doorbell easy hijacked Thanks to today's episode sponsor, Egress People are the biggest risk to your organizations' security and they are most vulnerable when using email. With more advanced threats getting through secure email gateway detection every day, Egress provides AI-powered email security that eliminates both inbound phishing attacks and outbound data breaches. What's more, Egress' adaptive security architecture personalizes security for each user based on their real-time risk score. Visit e...
2024-03-0108 min
Cyber BriefingFebruary 28, 2024 - Cyber Briefing
👉 What's trending in cybersecurity today?
🚨 #CyberAlerts
FBI, CISA, HHS Alert on BlackCat Ransomware Targeting US Hospitals
Source : CISA
Russian Hackers Exploit Ubiquiti Routers for Stealth Attacks
Source : IC3
TimbreStealer Malware Targets Mexicans via Tax-Themed Phishing Scam
Source : Guilherme Venere, Jacob Finn, Tucker Favreau, Jacob Stanfill, James Nutland via Cisco Talos Intelligence
New Atomic Stealer Variant Targets Safari Cookies and Crypto Wallets
Source : Andrei Lapusneanu via Bitdefender
Critical Flaw in LiteSpeed Cache Plugin Puts Millions of WordPress Sites at Ris...
2024-02-2810 min
Life After Tech BootcampOpera Singer to Data ScienceSid currently serves as a Senior Visualization Engineer at Cencora, where he holds a technical leadership role in Power BI development and crafts analytics solutions for Cencora’s pharmaceutical clients.In the fall of 2020, Sid completed the Springboard program, earning a certificate in Data Science. Prior to transitioning into data visualization, he spent 10 years as a professional opera singer.Sid discusses feeling initially intimidated as the sole musician in his program but highlights how his years of auditioning provided him with "an edge" during the job search. Moreover, he provides insights into effective networking strategies, br...
2024-02-281h 16
WithologySteve Collis (President and CEO of Cencora)-Ep. 11On this episode of Withology, Steve Collis, Chairman, President and CEO of Cencora sits down with Brian for an insightful and wide-ranging conversation. Together, they discuss Steve's journey from growing up in Johannesburg, South Africa to leading Cencora, a Fortune 20 company. Get the full show notes and more resources at Briancom.com/about.
2024-02-2133 minOnCallGPO Legislative Townhall December 2023: Part 11In this episode, the eleventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses drug pricing and shortages.If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2024-02-0808 minOnCallGPO Legislative Townhall December 2023: Part 10In this episode, the tenth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses transparency in the House, competition, and lower costs on drugs and services.Our next episode will feature information on drug pricing and shortages. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2024-02-0815 minOnCallGPO Legislative Townhall December 2023: Part 9In this episode, the ninth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses health issues around Medicare physician payment, and PBM reform.Our next episode will feature information on transparency in the House, competition, and lower costs on drugs and services. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2024-01-1112 min
InvestTalkInvestTalk 1-9-2024 – What's the Story on the SEC and a Bitcoin ETF?Against the backdrop of SEC Chair Gary Gensler’s long-running fight with the crypto industry, 13 companies have filed for a spot bitcoin ETF. Today's Stocks & Topics: PANW - Palo Alto Networks Inc., UBER - Uber Technologies Inc., Money Management, BA - Boeing Co., COR - Cencora Inc., Jobs Report, Interest and Economic Growth, APA - APA Corp., Blackstone Real Estate Income Trust Inc.Our Sponsors:* Check out Monarch Money and use my code INVESTTALK for a great deal: https://www.monarchmoney.com/* Check out Rosetta Stone and use my code TODA...
2024-01-1046 min
pharmaphorum PodcastThe race to develop innovative products and supply chain solutionsIn the final instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Cencora’s SVP of international commercialisation, Sandra Anderson, and SVP and international managing director of Alloga Europe and ICS, Chris Williams. The topic of discussion centres around considerations and challenges when it comes to launching a biopharmaceutical product in Europe.
2023-12-3024 minInvestTalkInvestTalk 11-30-2023 – Must-Knows About Employee Stock OptionsHow to balance the tax and investment considerations. Today's Stocks & Topics: OMF - OneMain Holdings Inc., COR - Cencora Inc., 401k Rollover, The Green Transition, AVB - Avalonbay Communities Inc., Apartment REITs, SWK - Stanley Black & Decker Inc., Investing in the Market, VTV - Vanguard Value ETF, ESG: Environmental, Social, and Governance.Our Sponsors:* Check out Greenlight.com/investtalk and try Greenlight for free.* Check out Rosetta Stone for a great deal: https://www.rosettastone.com/TODAYAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: ht...
2023-12-0146 minOnCallGPO Legislative Townhall August 2023: Part 8In this episode, the eighth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses MPFS, Medicare Drug Price Negotiations, PBM reform, and elections.That's all for this episode of OnCall. Our next episode will feature information on politics and policy, and physician payment issues. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2023-11-2928 min
Draugystė vežaDraugystė veža. Socialiniai įgūdžiai – tavo ateities valiutaJautrus pokalbis apie kiekvieno iš mūsų socialinę atsakomybę, apie tai, kaip svarbu dirbti įtraukioje darbovietėje, jausti, tiek vadovų, tiek kolegų palaikymą. Apie visuomenės sąmoningumą. Ir apie tai, kaip tai ilgalaikėje perspektyvoje visa tai gali gerinti visos šalies socialinę situaciją.„Socialiniai įgūdžiai – tavo ateities valiuta“, - laidoje sako pašnekovai: kompanijos „Cencora“ darbuotojai Aurelija Kuodzevičienė, Monika Judickienė ir Tomas Eicher Lorka. Abi moterys augina negalią turinčius vaikučius, o Tomas turi Aspergerio sindromą.Ved. Žydrė Gedrimaitė
2023-11-1828 min
Al Ahly PharosPre-Trading ThoughtsA digital platform for those looking for a fast-track golden investor license will be available within the next few days.Egyptian exports to African countries are projected to climb 10% to USD5.5 bn in 2023.US inflation declined for the first time since August to 3.2%, reassuring investors that the Fed’s aggressive tightening cycle is at an end.GBCO (FV: EGP10.55,OW) released 3Q23 financials showing: Auto’s attributable net profit recorded EGP475.3 mn (+49.3% YoY, +91.1% QoQ). GB Capital’s net profit reached EGP189 mn (-18.9% YoY, -25.4% QoQ), due to a rise in provis...
2023-11-1509 min
PharmaSource PodcastWorld Courier: Location Intelligence and the Personalised Supply ChainWorld Courier, a specialist in logistics, warehousing, and transportation services for the pharma and biopharma industry, covers the entire supply chain from preclinical stages and universities to commercial products.
With 50 years of experience in the storage and transportation of time and temperature-sensitive products, World Courier is part of the Cencora group (formerly AmerisourceBergen), allowing it to tap into a wider range of services.
Alan Runacus, UK Sales Manager, explains how World Courier supports pharma and biotechs of all sizes to access important markets.
“World Courier is not just about delivering packages; we ensure th...
2023-10-2211 min
Pharmacy FocusPharmacy Focus: Student Edition - Fostering Inclusivity: Scholarships for Black Student PharmacistsIn this episode of Pharmacy Focus: Student Edition, we dive deep into the world of scholarships designed to support Black student pharmacists. Guests Jenni Zilka and Samarah, a P2 student at the University of Toledo, discuss the Good Neighbor Pharmacy and Cencora scholarship funds. They discuss the significance in fostering inclusivity and the pivotal role of representation in the field of pharmacy.
Pharmacy Times Salary and Job Satisfaction Survey: https://s.surveyplanet.com/z5cp0c3r
Key Takeaways
Introduction to the Good Neighbor Pharmacy and Cencora scholarship funds
The profound importance of creating scholarships for B...
2023-09-1815 min
Pharmaceutical ExecutiveAvoiding Commercialization Pitfalls for CGTsCommercialization is a tough road to navigate even for the most established bio/pharmaceutical therapies. But as cell and gene therapies (CGTs) continue to form roots and make a splash worldwide—but specifically in the US—commercialization forms its own version of standardization and best practices.
In this exclusive interview with Pharmaceutical Executive, Lung-I Cheng, vice president of CGT, Cencora (formerly AmerisourceBergen), discusses:
1) defining CGT commercialization strategies and foundational knowledge—and the best music metaphor
2) what he wishes companies knew about commercialization strategies
3) common knowledge gaps of CGTs
4) how CGT developers can overcome key challenges, includ...
2023-09-1431 minOnCallGPO Legislative Townhall August 2023: Part 7In this episode, the seventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses Congress and the fiscal backdrop.Our next episode will feature information on issues regarding MPFS, Medicare Drug Price Negotiations, PBM reform, and elections. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2023-09-0716 minThe Talent Pool with Alan KaplanRedefining Incentive Compensation with Silvana Battaglia
Silvana Battaglia, EVP and CHRO at Cencora (formerly AmerisourceBergen), challenges executive compensation structures and shares new ideas on the role of ESG in defining corporate performance.
2023-09-0509 minOnCallGPO Legislative Townhall May 2023: Part 6In this episode, the sixth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses the new DEA proposed rules on prescribing controlled substances and treatments.Our next episode will feature information on payment updates for Medicare. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2023-08-1715 minOnCallGPO Legislative Townhall May 2023: Part 5In this episode, the fifth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses the End of the Public Health Emergency and what it means for practices.Our next episode will feature information on the New DEA proposed rules on prescribing controlled substances and treatments. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2023-08-0126 minOnCallGPO Legislative Townhall May 2023: Part 4In this episode, the fourth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses federal budget and debt negotiations and the implications for Medicare, Medicaid and ACA.Our next episode will feature information on the end of the Public Health Emergency and what it means for practices. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2023-07-2012 minOnCallGPO Legislative Townhall Feb 2023: Part 3In this episode, the third of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss the Inflation Reduction Act, PBM reform, and 2023 regulations.Our next episode will feature information on federal budget and debt negotiations and the implications for Medicare, Medicaid and ACA. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2023-07-0622 minOnCallGPO Legislative Townhall Feb 2023: Part 2In this episode, the second of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss drug coverage, pricing, and payment.Our next episode will feature information on the Inflation Reduction Act, PBM reform, and 2023 regulations. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2023-06-2218 minOnCallGPO Legislative Townhall Feb 2023: Part 1In this episode, the first of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss three important policy trends impacting physicians: Medicare payments, drugs/biologics, and disparities/SDOH.Our next episode will feature information on drug coverage, pricing, and payments. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2023-06-0713 minOnCallOperational Pathways for Biomarker Testing in NSCLCIn this Amgen sponsored podcast, David R. Braxton, MD, Chief of Service for Molecular Pathology at Hoag Hospital, shares his insights as considerations on operationalizing biomarker testing into clinical practice in NSCLC. He discusses considerations on improving the turnaround time of test results, clinical application of ctDNA testing as well as strategies for documentation of results for ease of retrieval. Sponsored by AmgenIf you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.
2023-03-2112 minOnCallBiosimilar Series: Part 5In this episode, the fifth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about operationalizing biosimilars into practice and the differences and similarities of this process for biosimilars versus their counterparts. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2022-09-2211 minOnCallBiosimilar Series: Part 4In this episode, the fourth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the role of the payer in relation to biosimilars, the formulary management process and the differences in treatment of biosimilars by Medicaid and Medicare. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
2022-09-0908 minOnCallBiosimilar Series: Part 3In this episode, the third of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the FDA approval process for biosimilars, the Biologics Price Competition and Innovation Act and safety issues or adverse effects related to biosimilar use. If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.
2022-08-2409 minOnCallBiosimilar Series: Part 2In this episode, the second of our biosimilar education series, Kathy Oubre, CEO of Pontchartrain Cancer Center, and Neil Udovich, Vice President of Sales for AmerisourceBergen Specialty GPOs, discuss the history of biosimilars, the reception of them in the medical community and their road ahead. If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.
2022-07-0115 minOnCallBiosimilar Series: Part 1In this episode, the first of our biosimilar education series, Kathy Oubre, CEO of Pontchartrain Cancer Center, and Neil Udovich, Vice President of Sales for AmerisourceBergen Specialty GPOs, discuss what biosimilars are (and aren’t), interchangeability with their reference products, and Kathy’s experience with adopting them into her practice.If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.
2022-06-3009 minOnCallBiomarkers: Emerging Targets and TechnologiesIn this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about biomarker testing in the community oncology setting - from the importance of emerging biomarkers to basket and umbrella trial designs.If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.The content and information contained in this podcast is sponsored by Elevation Oncology. This podcast is for educational, and informational pu...
2022-03-2511 minOnCallBiomarker Testing: A Closer Look at When, Who, and How to TestIn this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about biomarker testing in the community oncology setting - from the advantages and disadvantages of liquid biopsies to the benefits of ordering test panels.If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.The content and information contained in this podcast is sponsored by Elevation Oncology. This podcast is for ed...
2022-03-1114 minOnCallGermline Genetic TestingIn this podcast series brought to you by Invitae, oncology specialists who routinely integrate genetic information into their patients' treatment, discuss actionable options for implementing genomics-informed, personalized cancer care.In the first installment of this series, Dr. Rakesh Patel, Chief Medical Officer, Digital Health, and Dr. Peter Beitsch, Breast Surgical Oncologist, Past President of the American Society of Breast Surgeons, discuss common barriers for integrating genetic testing, and emerging digital health tools that can help health care practitioners scale the use of genomic information to help their patients.If you have any questions for today’s...
2022-03-0726 minOnCallBuy and Bill 101: Part 4In the final episode of our buy and bill series, we discuss reducing financial barriers for your patients and talk to Joe Baffone, CEO of Annexus Health, about the benefit of implementing efficient financial navigation programs within your practice.Visit our website for more information or to become a member and ensure you have access to all of our product discounts and rebates, consulting services, upcoming and archived educational content, and all other benefits of a free GPO membership.To learn more about our partners at Annexus Health, visit AnnexusHealth.com.If you...
2022-02-1611 minOnCallBuy and Bill 101: Part 3In this episode, we talk about the reimbursement aspect of the buy and bill model and the four key issues that could negatively impact the health of your revenue cycle.Click here to get in touch with us for more information on this or variety of other topics related to your specialty practice.If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.
2022-02-0217 minOnCallBiomarkers 101: Basics of Biomarker TestingIn this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about the basics of biomarker testing – from identifying common testing approaches to comparing DNA and RNA sequencing. If you have any questions for today’s guest or have a topic you would like to learn more about, email us at OnCall@cencora.com. The content and information contained in this podcast is sponsored by Elevation Oncology. This podcast is for educational, and informational purposes only. This...
2022-01-2113 minOnCallBuy and Bill 101: Part 2In this episode, we discuss the benefits of buy and bill, how to get reimbursed, steps to take for timely payment and the important role patient assistance plays to protect the practice from financial risk and protect your patients from financial toxicity. Click here to get in touch with us for more information on this or variety of other topics related to your specialty practice.If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.
2022-01-1913 minOnCallBuy and Bill 101: Part 1This is the first episode in our series covering buy and bill. As more drugs that utilize this payment model enter the market, we want to make sure you have the information needed for proper payment and reimbursement.This type of education is just one essential benefit of a free GPO membership. In this episode, we cover the many advantages of a GPO membership and begin our overview of the buy and bill process.Learn more about AmerisourceBergen Specialty GPOs.If you have any questions for today’s guests, or have a topic yo...
2022-01-1404 minOnCallNovel Agents and Toxicity Management 101The rise of genomic sequencing and use of novel agents in the new standard of cancer care has created new challenges in recognizing and managing toxicities.In this episode, we are joined by Dr. Ian Olver, medical oncologist, bioethicist, researcher and current Professorial Research Fellow in the School of Psychology at the University of Adelaide, to discuss strategies and tools to support community oncologists in keeping patients on effective drugs by better managing the associated toxicities.Learn more about our partners at VieCure.The content and information contained in this podcast...
2021-11-0823 minOnCallUsing AI Clinical Decision Support to Manage Cancer ComplexityThe average oncologist would need 29 hours a day to keep up with the advances in cancer care. There are new treatments, policies, drugs, toxicities, trials—and a shortage of oncologists and nurses. In this episode, we are joined by Dr. Fred Ashbury, co-founder and chief scientific officer at Viecure, to highlight the key areas where A.I. significantly improves your ability to treat patients effectively and efficiently while also adding value to your practice. Learn more about our partners at VieCure.The content and information contained in this podcast is provided [exc...
2021-10-2518 minOnCallParadigms, Policy and Pharmacogenomics: What community oncologists need to knowThe evolution of cancer care is advancing so quickly, it’s nearly impossible to keep up. Genetic sequencing has radically improved our ability to get the right drug to the right patient—improving outcomes for both patients and practices. But policy is unclear, lab testing is interpreted differently, and funding is available—but how do you get it?In this episode, we are joined by Dr. Howard McLeod (internationally recognized expert in precision medicine and medical director for precision medicine at the Geriatric Oncology Consortium) and Dr. Jai Patel (chair of the department of cancer pharmacology and pharma...
2021-10-1123 minOnCallClinical trials: How has precision medicine elevated the role of community oncology?Precision medicine is refocusing which clinical trials are possible, but we still have a ~5% participation rate and non-diverse patient demographic. Community oncology is the doorway to changing the face of clinical trials in the era of precision medicine. In this podcast, we talk about why, how and what’s in it for your practice to facilitate clinical trials in the community setting.Learn more about our partners at VieCure.Dr. Paul Bunn Jr., MD, FASCO: Dr. Bunn is a Distinguished Professor, VieCure Clinical Advisory Council Member, and James Dudley Endowed Chair in Lung...
2021-09-0322 minOnCallTreating with TIBSOVO: A targeted therapeutic option for patients with R/R mIDH1 AMLListen to a discussion between Jonathan Abbas, MD, and Mark Levis, MD, PhD.Please listen to additional safety information for TIBSOVO® (ivosidenib tablets) at the end of this presentation. Please visit TibsovoPro.com to review the Full Prescribing Information, including BOXED WARNING.
2021-08-0322 minOnCallOff Our Chests: A Discussion with Dr. John and Liza MarshallIn this episode, we met with Dr. John Marshall, a medical oncologist, Georgetown University professor and frequent guest speaker at ION Solutions events, and his wife, Liza Marshall, to discuss their book, “Off Our Chests: A Candid Tour Through the World of Cancer”. To learn more or purchase a copy of the book, visit OffOurChestsBook.com.If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.
2021-07-0825 minOnCallPrecision Medicine Series: Evolution Part 2In this episode Natasha Clinton, Director of Medical Affairs for IntrinsiQ Specialty Solutions, and Nicole Chambers, Senior Director of Corporate Services for ION Solutions, discuss the advancements in liquid and tissue biopsy testing as well as the improvements our partners are making in the precision medicine space.If you have any questions for today’s guests or a topic you would like to learn more about, let us know at OnCall@cencora.com.
2021-05-0414 minOnCallPrecision Medicine Series: Evolution Part 1In this episode, a part of our Precision Medicine series, Susan Weidner, Senior VP of IntrinsiQ Analytics, and Natasha Clinton, Director of Medical Affairs for IntrinsiQ Specialty Solutions, discuss the overall strategy for ION’s precision medicine program - from the creation of the Precision Medicine Advisory Panel to where we are headed in the future.If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.
2021-03-0911 minOnCallA Conversation with Annexus HealthIn this extended episode, Brian Ansay, President of ION and IPN Solutions, sat down with Joe Baffone, Co-Founder and CEO of Annexus Health, to discuss our partnership and the exciting opportunities available to our members. Reach out to your ION or IPN Solutions sales rep or visit the Annexus Health website to learn more.We want to make sure you are getting the most out of our content, so if you have a topic you would like to learn more about, let us know at OnCall@cencora.com.
2021-03-0836 min